Deutsche Bank’s Cellular Biomedicine Group, Inc. CBMG Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q1 | – | Sell |
-8,985
| Closed | -$165K | – | 4707 |
|
2020
Q4 | $165K | Buy |
8,985
+2,478
| +38% | +$45.5K | ﹤0.01% | 3507 |
|
2020
Q3 | $119K | Buy |
6,507
+599
| +10% | +$11K | ﹤0.01% | 3424 |
|
2020
Q2 | $89K | Buy |
5,908
+1,863
| +46% | +$28.1K | ﹤0.01% | 3450 |
|
2020
Q1 | $64K | Sell |
4,045
-246
| -6% | -$3.89K | ﹤0.01% | 3371 |
|
2019
Q4 | $68K | Buy |
4,291
+871
| +25% | +$13.8K | ﹤0.01% | 3702 |
|
2019
Q3 | $50K | Sell |
3,420
-5,948
| -63% | -$87K | ﹤0.01% | 3824 |
|
2019
Q2 | $152K | Sell |
9,368
-5,164
| -36% | -$83.8K | ﹤0.01% | 3882 |
|
2019
Q1 | $250K | Sell |
14,532
-636
| -4% | -$10.9K | ﹤0.01% | 3797 |
|
2018
Q4 | $267K | Sell |
15,168
-12,864
| -46% | -$226K | ﹤0.01% | 3638 |
|
2018
Q3 | $508K | Buy |
28,032
+5,834
| +26% | +$106K | ﹤0.01% | 3722 |
|
2018
Q2 | $435K | Buy |
22,198
+22,167
| +71,506% | +$434K | ﹤0.01% | 3849 |
|
2018
Q1 | $0 | Sell |
31
-92
| -75% | – | ﹤0.01% | 5059 |
|
2017
Q4 | $1K | Hold |
123
| – | – | ﹤0.01% | 4418 |
|
2017
Q3 | $1K | Hold |
123
| – | – | ﹤0.01% | 4323 |
|
2017
Q2 | $1K | Sell |
123
-2,915
| -96% | -$23.7K | ﹤0.01% | 4423 |
|
2017
Q1 | $35K | Sell |
3,038
-4,316
| -59% | -$49.7K | ﹤0.01% | 4043 |
|
2016
Q4 | $95K | Buy |
7,354
+5,262
| +252% | +$68K | ﹤0.01% | 3896 |
|
2016
Q3 | $30K | Buy |
2,092
+142
| +7% | +$2.04K | ﹤0.01% | 4094 |
|
2016
Q2 | $23K | Buy |
1,950
+493
| +34% | +$5.82K | ﹤0.01% | 4391 |
|
2016
Q1 | $26K | Sell |
1,457
-970
| -40% | -$17.3K | ﹤0.01% | 4263 |
|
2015
Q4 | $51K | Sell |
2,427
-288
| -11% | -$6.05K | ﹤0.01% | 4108 |
|
2015
Q3 | $45K | Buy |
2,715
+351
| +15% | +$5.82K | ﹤0.01% | 4197 |
|
2015
Q2 | $88K | Sell |
2,364
-1,136
| -32% | -$42.3K | ﹤0.01% | 4058 |
|
2015
Q1 | $110K | Buy |
+3,500
| New | +$110K | ﹤0.01% | 3863 |
|